BupivacaineCompartment syndrome following an off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1644卷 / 1期

关键词：

D O I：

10.1007/s40278-017-27833-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：61 / 61

相关论文

共 50 条

[1] SorafenibDRESS syndrome following off-label use: case report
Reactions Weekly, 2022, 1896 (1) : 420 - 420
[2] ModafinilDRESS syndrome following off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 322 - 322
[3] BrexpiprazolePisa Syndrome following off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 118 - 118
[4] BlinatumomabCytokine release syndrome following off-label use: case report
Reactions Weekly, 2021, 1867 (1) : 92 - 92
[5] HydroxychloroquineOcular myasthenic syndrome following off-label use: case report
Reactions Weekly, 2020, 1823 (1) : 189 - 189
[6] Azithromycin/hydroxychloroquineDRESS syndrome following off-label use: case report
Reactions Weekly, 2020, 1819 (1) : 60 - 60
[7] Hyaluronic acidNicolau syndrome following off-label use: case report
Reactions Weekly, 2021, 1864 (1) : 177 - 177
[8] QuetiapineNeuroleptic malignant syndrome following an off-label use: case report
Reactions Weekly, 2017, 1679 (1) : 172 - 172
[9] IvosidenibSweet's syndrome following an off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 270 - 270
[10] NivolumabFever following off-label use: case report
Reactions Weekly, 2016, 1601 (1) : 186 - 186

← 1 2 3 4 5 →